Nuyten Dimitry SA 4
4 · Arcus Biosciences, Inc. · Filed Sep 20, 2023
Insider Transaction Report
Form 4
Nuyten Dimitry SA
Chief Medical Officer
Transactions
- Disposition to Issuer
Common Stock
2023-09-18$20.40/sh−3,708$75,643→ 73,591 total
Footnotes (2)
- [F1]Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person.
- [F2]Includes 799 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan.